Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fractyl Health (GUTS) Operating Income (2023 - 2025)

Fractyl Health (GUTS) has disclosed Operating Income for 3 consecutive years, with -$22.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Income rose 4.62% year-over-year to -$22.7 million, compared with a TTM value of -$98.7 million through Sep 2025, down 21.45%, and an annual FY2024 reading of -$93.5 million, down 83.99% over the prior year.
  • Operating Income was -$22.7 million for Q3 2025 at Fractyl Health, up from -$26.1 million in the prior quarter.
  • Across five years, Operating Income topped out at -$11.9 million in Q2 2023 and bottomed at -$26.1 million in Q2 2025.
  • Average Operating Income over 3 years is -$19.8 million, with a median of -$22.7 million recorded in 2025.
  • The sharpest move saw Operating Income tumbled 94.21% in 2024, then increased 4.62% in 2025.
  • Year by year, Operating Income stood at -$13.0 million in 2023, then plummeted by 94.21% to -$25.2 million in 2024, then increased by 9.98% to -$22.7 million in 2025.
  • Business Quant data shows Operating Income for GUTS at -$22.7 million in Q3 2025, -$26.1 million in Q2 2025, and -$24.8 million in Q1 2025.